Transforming growth factor-β regulator SnoN modulates mammary gland branching morphogenesis, postlactational involution, and mammary tumorigenesis

Cancer Research

Volumn 70, Issue 10, 2010, Pages 4204-4213

  Jahchan, Nadine S ^a   You, Young Hyun ^a,c   Muller, William J ^b   Luo, Kunxin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; VIRUS T ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CARCINOGENESIS; CELL PROLIFERATION; EPITHELIUM CELL; FEMALE; FIBROBLAST; INVOLUTION; LACTATION; LUNG METASTASIS; MAMMARY GLAND; MORPHOGENESIS; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTO ONCOGENE; SNON GENE; TRANSGENIC MOUSE;

ADENOCARCINOMA; ANIMALS; BLOTTING, WESTERN; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LACTATION; LUNG NEOPLASMS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MORPHOGENESIS; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 77952835123     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-0135     Document Type: Article

References (50)

1. Siegel PM, Massague J. Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat Rev Cancer 2003;3:807-821 (Pubitemid 37376979)
2. Attisano L, Wrana JL. Signal transduction by the TGF-β superfamily. Science 2002;296:1646-1647
3. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 2003;425:577-584 (Pubitemid 37280136)
4. Massague J, Wotton D. Transcriptional control by the TGF-β/Smad signaling system. EMBO J 2000;19:1745-1754 (Pubitemid 30204386)
5. Moustakas A, Pardali K, Gaal A, Heldin CH. Mechanisms of TGF-β signaling in regulation of cell growth and differentiation. Immunol Lett 2002;82:85-91. (Pubitemid 34468039)
6. Stroschein SL, Wang W, Zhou S, Zhou Q, Luo K. Negative feedback regulation of TGF-β signaling by the SnoN oncoprotein. Science 1999;286:771-774 (Pubitemid 129515724)
7. Sun Y, Liu X, Ng-Eaton E, Lodish HF, Weinberg RA. SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor β signaling. Proc Natl Acad Sci U S A 1999; 96:12442-12447 (Pubitemid 29513521)
8. Akiyoshi S, Inoue H, Hanai J, et al. c-Ski acts as a transcriptional co-repressor in transforming growth factor-β signaling through interaction with smads. J Biol Chem 1999;274:35269-35277 (Pubitemid 129509586)
9. Luo K, Stroschein SL, Wang W, et al. The Ski oncoprotein interacts with the Smad proteins to repress TGFβ signaling. Genes Dev 1999; 13:2196-2206 (Pubitemid 29426725)
10. Wu JW, Krawitz AR, Chai J, et al. Structural mechanism of Smad4 recognition by the nuclear oncoprotein Ski: insights on Ski-mediated repression of TGF-β signaling. Cell 2002;111:357-367 (Pubitemid 35341390)
11. Boyer PL, Colmenares C, Stavnezer E, Hughes SH. Sequence and biological activity of chicken snoN cDNA clones. Oncogene 1993; 8:457-466 (Pubitemid 23073762)
12. Nomura N, Sasamoto S, Ishii S, Date T, Matsui M, Ishizaki R. Isolation of human cDNA clones of ski and the ski-related gene, sno. Nucleic Acids Res 1989;17:5489-5500 (Pubitemid 19187099)
13. Pearson-White S. SnoI, a novel alternatively spliced isoform of the ski protooncogene homolog, sno. Nucleic Acids Res 1993;21: 4632-4638 (Pubitemid 23292733)
14. Pearson-White S, Crittenden R. Proto-oncogene Sno expression, alternative isoforms and immediate early serum response. Nucleic Acids Res 1997;25:2930-2937 (Pubitemid 27299813)
15. Zhang F, Lundin M, Ristimaki A, et al. Ski-related novel protein N (SnoN), a negative controller of transforming growth factor-β signaling, is a prognostic marker in estrogen receptor-positive breast carcinomas. Cancer Res 2003;63:5005-5010 (Pubitemid 37022638)
16. Medrano EE. Repression of TGF-β signaling by the oncogenic protein SKI in human melanomas: consequences for proliferation, survival, and metastasis. Oncogene 2003;22:3123-3129
17. Bonni S, Wang HR, Causing CG, et al. TGF-β induces assembly of a Smad2-2 ubiquitin ligase complex that targets SnoN for degradation. Nat Cell Biol 2001;3:587-595 (Pubitemid 32536856)
18. Edmiston JS, Yeudall WA, Chung TD, Lebman DA. Inability of transforming growth factor-β to cause SnoN degradation leads to resistance to transforming growth factor-β-induced growth arrest in esophageal cancer cells. Cancer Res 2005;65:4782-4788
19. Imoto I, Pimkhaokham A, Fukuda Y, et al. SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus. Biochem Biophys Res Commun 2001;286:559-565 (Pubitemid 32912983)
20. Stroschein SL, Bonni S, Wrana JL, Luo K. Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN. Genes Dev 2001;15:2822-2836 (Pubitemid 33042053)
21. Zhu Q, Pearson-White S, Luo K. Requirement for the SnoN oncoprotein in transforming growth factor β-induced oncogenic transformation of fibroblast cells. Mol Cell Biol 2005;25:10731-10744 (Pubitemid 41747119)
22. Zhu Q, Krakowski AR, Dunham EE, et al. Dual role of SnoN in mammalian tumorigenesis. Mol Cell Biol 2007;27:324-339 (Pubitemid 46013254)
23. Shinagawa T, Dong HD, Xu M, Maekawa T, Ishii S. The sno gene, which encodes a component of the histone deacetylase complex, acts as a tumor suppressor in mice. EMBO J 2000;19:2280-2291 (Pubitemid 30259009)
24. Pan D, Zhu Q, Luo K. SnoN functions as a tumour suppressor by inducing premature senescence. EMBO J 2009;28:3500-3513
25. Hennighausen L, Robinson GW. Information networks in the mammary gland. Nat Rev Mol Cell Biol 2005;6:715-725
26. Sternlicht MD. Key stages in mammary gland development: the cues that regulate ductal branching morphogenesis. Breast Cancer Res 2006;8:201.
27. Robinson SD, Silberstein GB, Roberts AB, Flanders KC, Daniel CW. Regulated expression and growth inhibitory effects of transforming growth factor-β isoforms in mouse mammary gland development. Development 1991;113:867-878 (Pubitemid 21900326)
28. Bierie B, Moses HL. Tumour microenvironment: TGFβ: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 2006;6:506-520
29. Wakefield LM, Piek E, Bottinger EP. TGF-β signaling in mammary gland development and tumorigenesis. J Mammary Gland Biol Neoplasia 2001;6:67-82.
30. Pierce DF, Jr, Johnson MD, Matsui Y, et al. Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-β 1. Genes Dev 1993;7: 2308-2317
31. Pierce DF, Jr., Gorska AE, Chytil A, et al. Mammary tumor suppression by transforming growth factor β 1 transgene expression. Proc Natl Acad Sci U S A 1995;92:4254-4258
32. Gorska AE, Jensen RA, Shyr Y, Aakre ME, Bhowmick NA, Moses HL. Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-β receptor exhibit impaired mammary development and enhanced mammary tumor formation. Am J Pathol 2003;163:1539-1549 (Pubitemid 37175100)
33. Lenferink AE, Magoon J, Pepin MC, Guimond A, O'Connor-McCourt MD. Expression of TGF-β type II receptor antisense RNA impairs TGF-β signaling in vitro and promotes mammary gland differentiation in vivo. Int J Cancer 2003;107:919-928 (Pubitemid 37429833)
34. Forrester E, Chytil A, Bierie B, et al. Effect of conditional knockout of the type II TGF-β receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis. Cancer Res 2005;65: 2296-2302 (Pubitemid 40490139)
35. Gorska AE, Joseph H, Derynck R, Moses HL, Serra R. Dominantnegative interference of the transforming growth factor β type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice. Cell Growth Differ 1998;9: 229-238 (Pubitemid 28354303)
36. Guy CT, Cardiff RD, Muller WJ. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 1992;12:954-961
37. Guy CT, Muthuswamy SK, Cardiff RD, Soriano P, Muller WJ. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev 1994;8:23-32. (Pubitemid 24032850)
38. Bierie B, Stover DG, Abel TW, et al. Transforming growth factor-β regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment. Cancer Res 2008;68:1809-1819 (Pubitemid 351416566)
39. Muraoka-Cook RS, Shin I, Yi JY, et al. Activated type I TGFβ receptor kinase enhances the survival of mammary epithelial cells and accelerates tumor progression. Oncogene 2006;25:3408-3423 (Pubitemid 43877044)
40. Siegel PM, Shu W, Cardiff RD, Muller WJ, Massague J. Transforming growth factor β signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc Natl Acad Sci U S A 2003;100:8430-8435 (Pubitemid 36842562)
41. Yang YA, Tang B, Robinson G, et al. Smad3 in the mammary epithelium has a nonredundant role in the induction of apoptosis, but not in the regulation of proliferation or differentiation by transforming growth factor-β. Cell Growth Differ 2002;13:123-130 (Pubitemid 34507102)
42. Krakowski AR, Laboureau J, Mauviel A, Bissell MJ, Luo K. Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-β signaling by sequestration of the Smad proteins. Proc Natl Acad Sci U S A 2005;102:12437-12442 (Pubitemid 41266377)
43. Bascom JL, Fata JE, Hirai Y, Sternlicht MD, Bissell MJ. Epimorphin overexpression in the mouse mammary gland promotes alveolar hyperplasia and mammary adenocarcinoma. Cancer Res 2005;65: 8617-8621 (Pubitemid 41377346)
44. Novaro V, Roskelley CD, Bissell MJ. Collagen-IV and laminin-1 regulate estrogen receptor α expression and function in mouse mammary epithelial cells. J Cell Sci 2003;116:2975-2986 (Pubitemid 36926986)
45. Fata JE, Mori H, Ewald AJ, et al. The MAPK(ERK-1,2) pathway integrates distinct and antagonistic signals from TGFα and FGF7 in morphogenesis of mouse mammary epithelium. Dev Biol 2007;306: 193-207.
46. Pearson-White S, McDuffie M. Defective T-cell activation is associated with augmented transforming growth factor β sensitivity in mice with mutations in the Sno gene. Mol Cell Biol 2003;23:5446-5459 (Pubitemid 36950898)
47. Watson CJ. Involution: apoptosis and tissue remodelling that convert the mammary gland from milk factory to a quiescent organ. Breast Cancer Res 2006;8:203.
48. Chapman RS, Lourenco PC, Tonner E, et al. Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev 1999;13:2604-2616 (Pubitemid 29489651)
49. Qian W, Kashuba E, Magnusson KP, et al. Role of p53 mutation in polyomavirus-induced tumorigenesis. J Gen Virol 1997;78:893-903. (Pubitemid 27179756)
50. Qian W, Wiman KG. Polyoma virus middle T and small t antigens cooperate to antagonize p53-induced cell cycle arrest and apoptosis. Cell Growth Differ 2000;11:31-39 (Pubitemid 30078664)